Showing codes 24979-242-07 Zestril — 24979-710-51 Paclitaxel Protein-bound Particles For Injectable Suspension (albumin-bound)

24979-242-07 - Zestril
Firm: Upsher-Smith Laboratories, LLC
Package Description: 90 TABLET in 1 BOTTLE (24979-242-07)
Usage type: ORAL
HTML  TXT

24979-243-07 - Zestril
Firm: Upsher-Smith Laboratories, LLC
Package Description: 90 TABLET in 1 BOTTLE (24979-243-07)
Usage type: ORAL
HTML  TXT

24979-244-07 - Tenormin
Firm: Upsher-Smith Laboratories, LLC
Package Description: 90 TABLET in 1 BOTTLE (24979-244-07)
Usage type: ORAL
HTML  TXT

24979-245-07 - Tenormin
Firm: Upsher-Smith Laboratories, LLC
Package Description: 90 TABLET in 1 BOTTLE (24979-245-07)
Usage type: ORAL
HTML  TXT

24979-246-07 - Tenormin
Firm: Upsher-Smith Laboratories, LLC
Package Description: 90 TABLET in 1 BOTTLE (24979-246-07)
Usage type: ORAL
HTML  TXT

24979-247-06 - Forfivo
Firm: Upsher-Smith Laboratories, LLC
Package Description: 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (24979-247-06)
Usage type: ORAL
HTML  TXT

24979-248-06 - Bupropion Hydrochloride
Firm: Upsher-Smith Laboratories, LLC
Package Description: 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (24979-248-06)
Usage type: ORAL
HTML  TXT

24979-252-01 - Naproxen Sodium
Firm: Upsher-Smith Laboratories, LLC
Package Description: 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (24979-252-01)
Usage type: ORAL
HTML  TXT

24979-253-68 - Naproxen Sodium
Firm: Upsher-Smith Laboratories, LLC
Package Description: 75 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (24979-253-68)
Usage type: ORAL
HTML  TXT

24979-254-06 - Naproxen Sodium
Firm: Upsher-Smith Laboratories, LLC
Package Description: 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (24979-254-06)
Usage type: ORAL
HTML  TXT

24979-255-06 - Fluoxetine Hcl
Firm: TWi Pharmaceuticals, Inc.
Package Description: 30 TABLET, FILM COATED in 1 BOTTLE (24979-255-06)
Usage type: ORAL
HTML  TXT

24979-256-07 - Tenoretic
Firm: Upsher-Smith Laboratories, LLC
Package Description: 90 TABLET in 1 BOTTLE (24979-256-07)
Usage type: ORAL
HTML  TXT

24979-257-07 - Tenoretic
Firm: Upsher-Smith Laboratories, LLC
Package Description: 90 TABLET in 1 BOTTLE (24979-257-07)
Usage type: ORAL
HTML  TXT

24979-514-10 - Divalproex Sodium
Firm: TWi Pharmaceuticals, Inc.
Package Description: 100 TABLET, DELAYED RELEASE in 1 BOTTLE (24979-514-10)
Usage type: ORAL
HTML  TXT

24979-514-50 - Divalproex Sodium
Firm: TWi Pharmaceuticals, Inc.
Package Description: 500 TABLET, DELAYED RELEASE in 1 BOTTLE (24979-514-50)
Usage type: ORAL
HTML  TXT

24979-533-00 - Guanfacine
Firm: Upsher-Smith Laboratories, LLC
Package Description: 100000 TABLET, EXTENDED RELEASE in 1 DRUM (24979-533-00)
Usage type: ORAL
HTML  TXT

24979-533-01 - Guanfacine
Firm: Upsher-Smith Laboratories, LLC
Package Description: 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (24979-533-01)
Usage type: ORAL
HTML  TXT

24979-533-10 - Guanfacine
Firm: Upsher-Smith Laboratories, LLC
Package Description: 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (24979-533-10)
Usage type: ORAL
HTML  TXT

24979-534-00 - Guanfacine
Firm: Upsher-Smith Laboratories, LLC
Package Description: 100000 TABLET, EXTENDED RELEASE in 1 DRUM (24979-534-00)
Usage type: ORAL
HTML  TXT

24979-534-01 - Guanfacine
Firm: Upsher-Smith Laboratories, LLC
Package Description: 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (24979-534-01)
Usage type: ORAL
HTML  TXT

24979-534-10 - Guanfacine
Firm: Upsher-Smith Laboratories, LLC
Package Description: 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (24979-534-10)
Usage type: ORAL
HTML  TXT

24979-536-00 - Guanfacine
Firm: Upsher-Smith Laboratories, LLC
Package Description: 100000 TABLET, EXTENDED RELEASE in 1 DRUM (24979-536-00)
Usage type: ORAL
HTML  TXT

24979-536-01 - Guanfacine
Firm: Upsher-Smith Laboratories, LLC
Package Description: 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (24979-536-01)
Usage type: ORAL
HTML  TXT

24979-536-10 - Guanfacine
Firm: Upsher-Smith Laboratories, LLC
Package Description: 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (24979-536-10)
Usage type: ORAL
HTML  TXT

24979-538-00 - Guanfacine
Firm: Upsher-Smith Laboratories, LLC
Package Description: 100000 TABLET, EXTENDED RELEASE in 1 DRUM (24979-538-00)
Usage type: ORAL
HTML  TXT

24979-538-01 - Guanfacine
Firm: Upsher-Smith Laboratories, LLC
Package Description: 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (24979-538-01)
Usage type: ORAL
HTML  TXT

24979-538-10 - Guanfacine
Firm: Upsher-Smith Laboratories, LLC
Package Description: 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (24979-538-10)
Usage type: ORAL
HTML  TXT

24979-703-06 - Dexlansoprazole
Firm: TWI PHARMACEUTICALS, INC.
Package Description: 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (24979-703-06)
Usage type: ORAL
HTML  TXT

24979-704-06 - Dexlansoprazole
Firm: TWI PHARMACEUTICALS, INC.
Package Description: 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (24979-704-06)
Usage type: ORAL
HTML  TXT

24979-704-07 - Dexlansoprazole
Firm: TWI PHARMACEUTICALS, INC.
Package Description: 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (24979-704-07)
Usage type: ORAL
HTML  TXT

24979-710-51 - Paclitaxel Protein-bound Particles For Injectable Suspension (albumin-bound)
Firm: Upsher-Smith Laboratories, LLC
Package Description: 1 VIAL, SINGLE-USE in 1 CARTON (24979-710-51) / 20 mL in 1 VIAL, SINGLE-USE
Usage type: INTRAVENOUS
HTML  TXT